PCT (PCTL) Notes Receivable: $0.00 Mil (As of Sep. 2022)


What is PCT Notes Receivable?

PCT PCTL -99.00% Notes Receivable is $0.00 Mil as of Sep. 2022.

PCT's Notes Receivable for the quarter that ended in Sep. 2022 was $0.00 Mil.

PCT Notes Receivable Historical Data

* Premium members only.

The historical data trend for PCT's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PCT Notes Receivable Chart

PCT Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PCT Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PCT Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
PCT (PCTL) has a Notes Receivable of $0.00 Mil as of Sep. 2022. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PCT and its competitors.
Is PCT's Notes Receivable too high?
PCT's current Notes Receivable is $0.00 Mil.
How does PCT's Notes Receivable compare to EAWD and TOMZ?
PCT's Notes Receivable of $0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Industrial Products company?
A good Notes Receivable depends on the Industrial Products industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on PCT and its competitors. PCT's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCT stock overvalued right now?
PCT (PCTL) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For PCT (PCTL), the current Notes Receivable is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PCT Business Description

Address 4235 Commerce Street, Little River, SC, USA, 29566
PCT Ltd is a technology licensing company specializing in environmentally safe solutions for global sustainability. The company provides innovative products and technologies for eliminating contamination from water supplies, industrial fluids, hard surfaces, food processing equipment, and medical devices. The company markets new products and technologies for the Healthcare, Agriculture, and Oil & Gas industries. It designs, develops, integrates, assembles and commercializes technologies, products and systems targeted at the prevention and treatment of infectious disease and crop infestation. Its products include The Annihilyzer System, Large Volume Systems, Small Volume Systems, The Survivalyte System, and others.